Holen Sie sich die Stockscreener-App
2.52
0.40%
0.01
Handel nachbörslich:
2.61
0.09
+3.57%
Schlusskurs vom Vortag:
$2.51
Offen:
$2.53
24-Stunden-Volumen:
3.22M
Relative Volume:
0.45
Marktkapitalisierung:
$710.61M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-225.14M
KGV:
-1.2857
EPS:
-1.96
Netto-Cashflow:
$-192.27M
1W Leistung:
+0.80%
1M Leistung:
+1.61%
6M Leistung:
+236.00%
1J Leistung:
+446.05%
1-Tages-Spanne:
$2.52
$2.78
1-Wochen-Bereich:
$2.37
$2.78
52-Wochen-Spanne:
$0.3546
$3.0699
Invivyd Inc Stock (IVVD) Company Profile
Firmenname
Invivyd Inc
Sektor
Branche
Telefon
(781) 819-0080
Adresse
209 CHURCH STREET, NEW HAVEN
Vergleichen Sie IVVD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IVVD
Invivyd Inc
|
2.52 | 707.79M | 0 | -225.14M | -192.27M | -1.96 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.86 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
796.55 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.29 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
788.49 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.97 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Invivyd Inc Stock (IVVD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-22 | Eingeleitet | BTIG Research | Buy |
| 2025-11-25 | Herabstufung | D. Boral Capital | Buy → Hold |
| 2025-10-06 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-04-05 | Hochstufung | Guggenheim | Neutral → Buy |
| 2024-03-26 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2023-12-19 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2023-05-01 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Invivyd Inc Aktie (IVVD) Neueste Nachrichten
Invivyd granted FDA fast track status for COVID therapy - MSN
Why Analysts See Invivyd (IVVD) Story Shifting After REVOLUTION Program And US$10 Target - Yahoo Finance
Will Invivyd's DECLARATION Trial Send IVVD Stock Higher In 2026? - RTTNews
Why Invivyd Inc. stock is trending among retail traders2025 Earnings Surprises & Free Reliable Trade Execution Plans - ulpravda.ru
Invivyd reports 25% growth in Q4 PEMGARDA revenue to $17.2 million - Investing.com Australia
Invivyd Reports Strong PEMGARDA Growth and Advances VYD2311 - TipRanks
Invivyd, Inc. Reports Preliminary Q4 2025 Revenue of $17.2 Million and Announces Key Clinical Developments - Quiver Quantitative
Invivyd Reports Preliminary Fourth Quarter 2025 Revenue and Recent Business Highlights - The Manila Times
Press Release: Invivyd Reports Preliminary Fourth Quarter 2025 Revenue and Recent Business Highlights - 富途牛牛
Aug Gainers: Why Heiwa Real Estate Co Ltd HZJ stock appears on watchlistsDividend Hike & Growth Focused Entry Reports - moha.gov.vn
Invivyd Inc. | Latest News & Innovations - shababeek.org
BTIG initiates Invivyd (IVVD) coverage, cites VYD2311’s superior market potential over Pemgarda - MSN
BTIG Initiates Invivyd (IVVD) Coverage, Cites VYD2311’s Superior Market Potential Over Pemgarda - Insider Monkey
Invivyd (NASDAQ:IVVD) Trading Down 3.7%Here's Why - MarketBeat
Is Invivyd Inc. stock supported by strong fundamentalsChart Pattern Recognition & Minimal Risk High Reward - bollywoodhelpline.com
Does Invivyd’s (IVVD) Index Debut Reveal a Turning Point in Its Biotech Credibility? - Yahoo Finance
BTIG Reiterates Invivyd (IVVD) Buy Recommendation - Nasdaq
BTIG Research Upgrades Invivyd (NASDAQ:IVVD) to Strong-Buy - MarketBeat
FDA grants fast track designation for Invivyd’s COVID antibody By Investing.com - Investing.com Nigeria
Invivyd begins phase 3 trial of COVID prevention antibody VYD2311 By Investing.com - Investing.com Nigeria
US OPEN: Markets wobble amid low volumes and resilient GDP (23.12.2025) - XTB.com
Is Invivyd’s (IVVD) Index Debut Quietly Reframing Its Long-Term Biotech Positioning? - simplywall.st
Invivyd wins FDA fast track tag for COVID drug (IVVD:NASDAQ) - Seeking Alpha
Invivyd Says Vaccine-Alternative Antibody to Prevent COVID Gets FDA Fast Track Designation; Phase 3 Trial Launched - marketscreener.com
Invivyd’s COVID Antibody VYD2311 Receives FDA Fast Track - TipRanks
FDA grants fast track designation for Invivyd’s COVID antibody - Investing.com India
Invivyd Earns Fast Track Designation for VYD2311, a Vaccine-Alternative Antibody to Prevent COVID - The Manila Times
Invivyd announces initiation of DECLARATION clinical trial, a phase 3 placebo-controlled pivotal study of VYD2311, a vaccine-alternative antibody to prevent Covid-19 - marketscreener.com
Invivyd stock rises after FDA grants Fast Track designation for COVID antibody - Investing.com Canada
Invivyd, Inc. Earns Fast Track Designation for COVID Antibody - TradingView — Track All Markets
Invivyd rises as drugmaker starts late-stage trial for COVID prevention antibody - TradingView — Track All Markets
Invivyd begins phase 3 trial of COVID prevention antibody VYD2311 - Investing.com
FDA puts COVID prevention shot alternative from Invivyd on Fast Track - Stock Titan
New antibody shot aims to offer vaccine-alternative protection from COVID - Stock Titan
Invivyd (IVVD): Assessing Valuation After S&P Biotechnology Select Industry Index Inclusion - Yahoo Finance
This Blacksky Technology Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Sahm
Invivyd announces proposed public offering of common stock - MSN
Invivyd, Inc. (IVVD): Advancing RSV antibody VBY329 amid analyst downgrade - MSN
Invivyd (NASDAQ:IVVD) Shares Gap UpShould You Buy? - MarketBeat
BTIG Initiates Invivyd at Buy With $10 Price Target - marketscreener.com
Invivyd stock initiated with Buy rating at BTIG on COVID antibody potential - Investing.com India
Invivyd stock initiated with Buy rating at BTIG on COVID antibody potential By Investing.com - Investing.com South Africa
BTIG Initiates Coverage of Invivyd (IVVD) with Buy Recommendation - Nasdaq
Invivyd, Inc.(NasdaqGM: IVVD) added to S&P Biotechnology Select Industry Index - marketscreener.com
Invivyd, Inc.(NasdaqGM: IVVD) added to NASDAQ Biotechnology Index - marketscreener.com
Invivyd, Inc. (NASDAQ:IVVD) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Invivyd Inc (IVVD) Stock News & Articles - 24/7 Wall St.
Aug Sentiment: Is Invivyd Inc. stock undervalued vs historical averagesWeekly Investment Summary & Smart Swing Trading Alerts - Улправда
How Invivyd Inc. stock reacts to Fed rate cutsProduct Launch & Technical Pattern Alert System - ulpravda.ru
Is Invivyd Inc. stock a good choice for value investorsJuly 2025 Gainers & Long Hold Capital Preservation Plans - Улправда
Finanzdaten der Invivyd Inc-Aktie (IVVD)
Umsatz
Nettogewinn
Free Cashflow
ENV
Invivyd Inc-Aktie (IVVD) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| MCLAUGHLIN KEVIN F | Director |
Nov 19 '25 |
Buy |
2.50 |
50,000 |
125,000 |
50,000 |
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):